Phathom Pharmaceuticals reported cash from operations of -$1.93M and free cash flow of -$1.93M for the quarter ended Jun 2026, up 96.9% year over year. This cash flow statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||
| Net Income | -34.61M | -35.81M | -40.66M | -50.92M | -51.08M | -54.96M | -37.83M | -40.97M | -43.05M | -79.56M | -82.81M | -91.44M | -85.57M | -74.50M | -94.29M | -75.66M | -29.97M | -21.14M | -29.54M | -17.56M | ||||||||||||
| Share-based CompensationStock Comp. | 4.42M | 4.34M | 5.78M | 5.88M | 5.82M | 6.66M | 7.05M | 7.25M | 6.14M | 24.58M | 6.26M | 6.54M | 6.45M | 6.69M | 7.05M | 9.67M | 18.80M | 5.61M | 20.10M | 18.10M | ||||||||||||
| Gains from Investment SecuritiesGains Investment | ||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.24M | 0.47M | 0.12M | 0.90M | -0.08M | -0.54M | ||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -29.07M | -41.26M | -44.76M | -25.72M | -35.02M | -41.04M | -39.67M | -22.20M | -31.91M | -43.80M | -69.02M | -70.72M | -63.57M | -63.46M | -84.93M | -62.73M | -14.12M | -5.00M | -15.65M | -1.93M | ||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 2.39M | 0.51M | 0.52M | 0.53M | 0.56M | 0.50M | 0.50M | 0.27M | 0.54M | 0.57M | 0.47M | 0.50M | 0.59M | 0.63M | 0.70M | 0.73M | 0.78M | 0.81M | 0.84M | 0.91M | ||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.13M | 0.14M | 0.13M | 0.15M | 0.17M | 0.17M | 0.15M | 0.12M | 0.12M | 0.18M | 0.21M | 0.20M | 0.19M | 0.19M | 0.18M | 0.17M | 0.16M | 0.13M | 0.11M | 0.11M | ||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 1.64M | 2.24M | 7.00M | 10.18M | 17.75M | -2.43M | 14.89M | 4.53M | 22.34M | 2.60M | 16.70M | |||||||||||||||||||||
| Change in InventoryChange Inventory | 0.11M | 9.33M | 0.42M | -0.27M | 0.42M | 5.58M | 12.33M | 1.85M | -0.40M | -2.00M | -0.67M | 3.96M | ||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 3.23M | -0.16M | -6.08M | 8.94M | 1.90M | 3.92M | -11.30M | 2.86M | 4.59M | 10.27M | -5.01M | 8.69M | 11.32M | 19.94M | -6.96M | 12.38M | 1.11M | 27.57M | -3.12M | 23.40M | ||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.01M | 0.10M | 0.12M | 0.38M | 0.13M | 0.41M | 0.21M | 0.01M | 3.23M | -1.82M | 0.04M | 0.05M | 0.04M | 0.01M | 0.04M | 0.07M | 0.03M | 1.08M | 0.17M | |||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.01M | -0.10M | -0.07M | -0.43M | -0.13M | -0.41M | -0.21M | -0.01M | -0.94M | -0.47M | -0.04M | -0.05M | -0.04M | -0.01M | -0.02M | -0.10M | -0.03M | -0.09M | -0.06M | -0.04M | ||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 1.26M | 0.16M | 0.01M | 172.58M | 0.28M | 1.30M | 0.08M | 0.29M | 1.26M | 0.59M | 3.55M | |||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 44.03M | 0.16M | 24.60M | 14.07M | 141.50M | 0.01M | 211.99M | 9.90M | 24.77M | 122.06M | 26.05M | 0.08M | -0.27M | -0.10M | 66.64M | 3.55M | ||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.73M | 1.24M | 1.74M | 1.04M | 2.49M | 1.87M | 2.28M | 0.95M | 4.82M | 0.34M | ||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 24.60M | 14.07M | 0.00M | 38.70M | ||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||
| Change in Cash | 14.95M | -41.20M | -44.82M | 69.30M | -10.55M | -41.45M | -25.81M | 119.30M | -32.84M | 167.72M | -59.16M | -46.00M | 58.44M | -37.41M | -84.95M | -62.75M | -14.41M | -5.18M | 50.93M | 1.58M | ||||||||||||
| Free Cash FlowFCF | -29.08M | -41.36M | -44.88M | -26.09M | -35.15M | -41.45M | -39.88M | -22.21M | -35.14M | -41.98M | -69.06M | -70.77M | -63.62M | -63.46M | -84.97M | -62.80M | -14.14M | -6.08M | -15.82M | -1.93M | ||||||||||||
| Net Cash FlowNCF | 14.95M | -41.20M | -44.82M | -26.14M | -10.55M | -41.45M | -25.81M | 119.30M | -32.84M | 167.72M | -59.16M | -46.00M | 58.44M | -37.41M | -84.95M | -62.75M | -14.41M | -5.18M | 50.93M | 1.58M |